How we deliver research

We have built a reputation as a flexible and responsive funder, committed to supporting the best and most innovative ideas from across the field.

From basic science through to early drug discovery and clinical trials. Here you can find out more about our research strategy, as well as the grants review process and global partnerships.

ientist looking at brain scans

Our research strategy

Our focus is to accelerate the ‘bench-to-bedside’ journey: our funding seeks to translate scientific findings into patient benefit as rapidly as possible. 

Find out more
A scientist using equipment on a laboratory bench

The grants review process

Alzheimer’s Research UK is a member of the Association of Medical Research Charities and follows their guidelines for best practice in peer review. Grants are awarded on scientific merit in relation to Alzheimer's Research UK’s remit and on the basis of open competition.

Find out more
Our research portfolio

Our research portfolio

Our current total research investment is £27.65m, totalling 111 projects across 3 continents.

Find out more
A researcher inspecting laser equipment in a laboratory

Measuring impact

We monitor the progress and impact of the research that we fund in a number of ways.

Find out more
AMRC Peer Review Audit 2015

AMRC Peer Review Audit 2015

Alzheimer's Research UK meets all the principles of the AMRC's peer review audit for 2015.

Find out more
Our UK and global partnerships

Our UK and global partnerships

Alzheimer’s Research UK is a partner in a number of consortia and other research initiatives, both within the UK and internationally, which aim to accelerate progress in dementia research.

Find out more